Premium
3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline (Adv. Healthcare Mater. 14/2025)
Author(s) -
Yang Xingyun,
Artibani Mara,
Jin Yongcheng,
Aggarwal Aneesh,
Zhang Yujia,
MuñozGalvan Sandra,
Mikhailova Ellina,
Rai Lena,
Mukherjee Nobina,
Kumar Ravinash Krishna,
Albukhari Ashwag,
Ma Shaohua,
Zhou Linna,
Ahmed Ahmed Ashour,
Bayley Hagan
Publication year - 2025
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.202570082
Minimal Residual Disease The cover image depicts 3D microtumors created with a microfluidic system. The microtumors retain key features of ovarian cancer minimal residual disease (MRD), a major cause of cancer recurrence. The in vitro model serves as a platform for testing therapeutics, and can support personalized treatment. More details can be found in article 2404072 by Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley, and co‐workers.